                         SEQUENCE LISTING

<110>  Emory University
 
<120>  PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS
        INFECTIONS

<130>  061825-00311

<140>  PCT/US2020/036171
<141>  2020-06-04

<150>  62/857,674
<151>  2019-06-05

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  DNA
<213>  human

<400>  1
tgcccgccat catccta                                                      17


<210>  2
<211>  21
<212>  DNA
<213>  human

<400>  2
tcctcatcgc cctcccatcc c                                                 21


<210>  3
<211>  23
<212>  DNA
<213>  human

<400>  3
cgtctgttat gtaaaggatg cgt                                               23


<210>  4
<211>  17
<212>  DNA
<213>  human

<400>  4
gcgcggctac agcttca                                                      17


<210>  5
<211>  18
<212>  DNA
<213>  human

<400>  5
caccacggcc gagcggga                                                     18


<210>  6
<211>  22
<212>  DNA
<213>  human

<400>  6
tctccttaat gtcacgcacg at                                                22


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic 15mer peptide with sequence corresponding to an 
       autocleavage site of the SARS-3CLPro

<400>  7

Ser Ile Thr Ser Ala Val Leu Gln Ser Gly Phe Arg Lys Met Ala 
1               5                   10                  15  


<210>  8
<211>  20
<212>  DNA
<213>  SARS-CoV-2

<400>  8
gaccccaaaa tcagcgaaat                                                   20


<210>  9
<211>  24
<212>  DNA
<213>  SARS-CoV-2

<400>  9
tctggttact gccagttgaa tctg                                              24


<210>  10
<211>  24
<212>  DNA
<213>  SARS-CoV-2

<400>  10
accccgcatt acgtttggtg gacc                                              24


